Company Comparison
Tyra Biosciences vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Tyra Biosciences | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Carlsbad, California | South San Francisco, California |
| Founded | 2018 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $200M | — |
| Valuation | — | — |
What They Build
Tyra Biosciences
Precision oncology company developing targeted therapies for patients with cancer driven by specific genetic alterations.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Tyra Biosciences
Sector Overlap
Both Tyra Biosciences and 23andMe operate in Biotech.
Browse all Biotech companies →